Medicus Pharma Ltd MDCX
News
-
Medicus Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update
-
New to The Street to Broadcast Nationwide on Bloomberg Television Tonight at 6:30 PM ET Featuring RHINO Bitcoin, Marina Decisions, Medicus Pharma and Virtuix Holdings
-
Medicus Pharma Shares Rise After Filing of FDA Priority-Voucher Application
Trading Information
- Previous Close Price
- $5.10
- Day Range
- $0.09–0.12
- 52-Week Range
- $4.71–139.00
- Bid/Ask
- $0.09 / $0.10
- Shares Outstanding
- 1.50M
- Market Cap
- $7.31M
- Volume/Avg
- 11M / 91,813
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Small Core
- Total Number of Employees
- 16
- Website
- https://www.medicuspharma.com
Valuation
|
Metric
|
MDCX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
MDCX
|
|---|---|
Quick Ratio | 1.40 |
Current Ratio | 1.57 |
Interest Coverage | −56.19 |
Quick Ratio
MDCX
Profitability
|
Metric
|
MDCX
|
|---|---|
Return on Assets (Normalized) | −306.66% |
Return on Equity (Normalized) | −11,125.56% |
Return on Invested Capital (Normalized) | −456.22% |
Return on Assets
MDCX
Drug Manufacturers - General Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Eli Lilly and Co
LLY
| LOCK|?<z%>Vf% | LOCK|X!c | $1T | |||
| Johnson & Johnson
JNJ
| LOCK|KjP!$l^ | LOCK|>Y | $618B | |||
| AbbVie Inc
ABBV
| LOCK|Y?Jgy? | LOCK|y&$ | $481B | |||
| Merck & Co Inc
MRK
| LOCK|JX>Ql! | LOCK|ZN | $351B | |||
| Roche Holding AG ADR
RHHBY
| LOCK|T$<N%?L | LOCK|?d | $338B | |||
| Novartis AG ADR
NVS
| LOCK|jm><rTMS | LOCK|>V | $269B | |||
| AstraZeneca PLC
AZN
| LOCK|!BsV##$> | LOCK|<X# | $244B | |||
| Amgen Inc
AMGN
| LOCK|RT#pK%L | LOCK|K$D | $220B | |||
| Gilead Sciences Inc
GILD
| LOCK|&NZK@p! | LOCK|#VH | $182B | |||
| Novo Nordisk AS ADR
NVO
| LOCK|%QCm@l | LOCK|KC | $165B |
United States